PhoenixBio Co.,Ltd.
TSE Growth
¥320.00
+0.95%
Delayed · cached 15 min
Fair value analysis
6190
PhoenixBio Co.,Ltd.
¥320.00
Close used for this calculation
¥378.69Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
53/100
Quality radar
Consensus fair value
¥378.69
Below FV▲ +18.3% against the close used
Model range ¥225.16 – ¥616.20
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥225.16Fair value¥378.69Bull¥616.20
FairClose
52-week traded range
52W low ¥317.0052W high ¥678.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
PhoenixBio Co.,Ltd. closed at ¥320.00, 15.5% below the consensus fair value of ¥378.69 drawn from 7 valuation models.
Financial DNA score 53/100 — Good. P/E of 10.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥260.19
-18.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
¥510.86
+59.6%
√(22.5 × EPS × BVPS)
EPS=30.81, BVPS=376.47
P/E Fair Value
¥616.20
+92.6%
EPS × 20x (sector P/E)
EPS=30.81, Sector P/E=20x
EV/EBITDA
¥225.16
-29.6%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=116.52M
Book Value (P/B)
¥304.94
-4.7%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=376.47, ROE=8.7%, g=3%, r=10%
Reverse DCF
¥320.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -1.8% | Historical: 0%
Margin of Safety
¥346.81
+8.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=462.42, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.